{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:05:57Z","timestamp":1740175557859,"version":"3.37.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T00:00:00Z","timestamp":1427760000000},"content-version":"vor","delay-in-days":211,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bmhimx.2014.07.002","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T17:17:13Z","timestamp":1432055833000},"page":"315-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tratamiento del s\u00edndrome nefr\u00f3tico idiop\u00e1tico en ni\u00f1os"],"prefix":"10.1016","volume":"71","author":[{"given":"Luis","family":"Vel\u00e1squez Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2008","series-title":"Proteinuria y S\u00edndrome Nefr\u00f3tico en ni\u00f1os","author":"Vel\u00e1squez","key":"10.1016\/j.bmhimx.2014.07.002_bib0005"},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/adc.83.1.45","article-title":"Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials","volume":"83","author":"Hodson","year":"2000","journal-title":"Arch Dis Child."},{"issue":"Suppl 2","key":"10.1016\/j.bmhimx.2014.07.002_bib0015","first-page":"139","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0020","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.1981.209","article-title":"Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and diffuse mesangial hypercellularity. A report of the International Study of Kidney Disease in Children","volume":"20","year":"1981","journal-title":"Kidney Int."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0025","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"1","author":"Hodson","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0030","series-title":"Pediatric nephrology","first-page":"667","article-title":"Idiopathic nephrotic syndrome in children: Clinical aspects","author":"Niaudet","year":"2009"},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","volume":"98","year":"1981","journal-title":"J Pediatr."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","article-title":"Children with steroid-sensitive nephrotic syndrome come of age: Long-term outcome","volume":"147","author":"R\u00fcth","year":"2005","journal-title":"J Pediatr."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0045","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1007\/s00467-005-1964-z","article-title":"Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: Current status and future directions","volume":"20","author":"Moudgil","year":"2005","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0050","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00467-005-1957-y","article-title":"Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome","volume":"20","author":"Novak","year":"2005","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","article-title":"Mycophenolate mofetil for steroid-dependent nephrotic syndrome: A phase II Bayesian trial","volume":"27","author":"Baudouin","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","article-title":"A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome","volume":"22","author":"Fujinaga","year":"2007","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0065","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","article-title":"Rituximab therapy for steroid-dependent minimal change nephrotic syndrome","volume":"21","author":"Gilbert","year":"2006","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0070","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe end effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiophatic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrneph.2013.153","article-title":"Nephrotic syndrome: Rituximab in childhood steroid-dependent nephrotic syndrome","volume":"9","author":"Boyer","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00467-012-2361-z","article-title":"Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?","volume":"28","author":"Delbe-Bertin","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0085","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00467-009-1195-9","article-title":"Fatal pulmonary fibrosis after rituximab administration","volume":"24","author":"Chaumais","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0090","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00467-013-2485-9","article-title":"Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome","volume":"28","author":"Sellier-Leclerc","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0095","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","article-title":"Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome","volume":"15","author":"Ruf","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00467-006-0019-4","article-title":"Clinical course of 110 children and adolescents with primary focal segmental glomerulosclerosis","volume":"21","author":"Abrantes","year":"2006","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-006-0301-5","article-title":"Primary focal segmental glomerular sclerosis in children: Clinical course and prognosis","volume":"22","author":"Paik","year":"2007","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00467-006-0310-4","article-title":"Therapeutic approach to FSGS in children","volume":"22","author":"Gipson","year":"2007","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: New guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0120","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00467-005-2097-0","article-title":"Differential risk of remission and ESRD in childhood FSGS","volume":"21","author":"Gipson","year":"2006","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0130","series-title":"Clinical pediatric nephrology","first-page":"155","article-title":"Nephrotic syndrome","author":"Valentini","year":"2007"},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0135","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00467-013-2509-5","article-title":"Late steroid resistance in childhood nephrotic syndrome: Do we now know more than 40 years ago?","volume":"28","author":"Akchurin","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0140","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00467-013-2483-y","article-title":"Treatment outcome of late steroid-resistant nephrotic syndrome: a study by the Midwest Pediatric Nephrology Consortium","volume":"28","author":"Straatmann","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.V132388","article-title":"Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome","volume":"13","author":"Karle","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000186354","article-title":"Steroid-resistant idiopathic nephrotic syndrome and cyclosporin","volume":"57","author":"Niaudet","year":"1991","journal-title":"Nephron."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0155","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1093\/ndt\/gfh320","article-title":"Nephrotic focal segmental glomerulosclerosis in 2004: An update","volume":"19","author":"Meyrier","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0160","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00467-012-2393-4","article-title":"Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis","volume":"28","author":"Hamasaki","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0165","first-page":"109","article-title":"Tratamiento con ciclosporina en ni\u00f1os con s\u00edndrome nefr\u00f3tico corticorresistente","volume":"53","author":"Vel\u00e1squez","year":"1996","journal-title":"Bol Med Hosp Infant Mex."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0170","first-page":"1804","article-title":"Efficacy of prednisone-tacrolimus vs. prednisone-cyclosporine in steroid-resistant nephrotic syndrome. The Fifteenth Congress of the International Pediatric Nephrology Association","volume":"25","author":"Valverde","year":"2010","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0175","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","article-title":"Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome","volume":"27","author":"Wang","year":"2012","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0180","first-page":"144","article-title":"Ineficacia de la mostaza nitrogenada en el tratamiento del s\u00edndrome nefr\u00f3tico corticorresistente","volume":"55","author":"Salda\u00f1a","year":"1998","journal-title":"Bol Med Hosp Infant Mex."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00467-003-1095-3","article-title":"Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome","volume":"18","author":"Bajpai","year":"2003","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0190","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s004670050167","article-title":"Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children","volume":"10","author":"Tarshish","year":"1996","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5414\/CNP65007","article-title":"Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis","volume":"65","author":"Buyukcelik","year":"2006","journal-title":"Clin Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0200","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00467-008-0794-1","article-title":"Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome\u2014a randomized controlled multicentre trial by the Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie","volume":"23","author":"Plank","year":"2008","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0205","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ki.2011.195","article-title":"Clinical trial of focal and segmental glomerulosclerosis in children and young adults","volume":"80","author":"Gipson","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0210","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and-dependent nephrotic syndrome: Multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrneph.2012.289","article-title":"Rituximab therapy in nephrotic syndrome: Implications for patients\u2019 management","volume":"9","author":"Sinha","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","article-title":"Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00467-003-1314-y","article-title":"Enalapril dosage in steroid-resistant nephrotic syndrome","volume":"19","author":"Bagga","year":"2004","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.bmhimx.2014.07.002_bib0230","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/ajt.12045","article-title":"Recent progress in the pathophysiology and treatment of FSGS recurrence","volume":"13","author":"Cravedi","year":"2013","journal-title":"Am J Transplant."}],"container-title":["Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1665114614000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1665114614000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T14:40:17Z","timestamp":1652020817000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665114614000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1665114614000318"],"URL":"https:\/\/doi.org\/10.1016\/j.bmhimx.2014.07.002","relation":{},"ISSN":["1665-1146"],"issn-type":[{"type":"print","value":"1665-1146"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tratamiento del s\u00edndrome nefr\u00f3tico idiop\u00e1tico en ni\u00f1os","name":"articletitle","label":"Article Title"},{"value":"Bolet\u00edn M\u00e9dico del Hospital Infantil de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.bmhimx.2014.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Hospital Infantil de M\u00e9xico Federico G\u00f3mez. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}